HOME >> BIOLOGY >> NEWS
The BBVA Foundation commits 2.4 million euros to research in Ecology and Conservation Biology

The BBVA Foundation approves funding for 12 major research projects in Ecology and Conservation Biology, with a total allocation of 2.4 million euros.

Among the projects selected in the 4th BBVA Foundation Call for Research Proposals we can single out a scientific study into the impact of climate change on populations of shorebirds (birds living mainly in coastal or wetland areas on marshes, mudflats or beaches). Many shorebird species migrate long distances and can cover thousand of kilometers in each annual cycle between their breeding and their wintering areas. This makes them highly vulnerable to changing climatic conditions in different zones: with 48% of the worlds known populations suffering decline. And there are reasons to fear that the trend will accelerate, with most climate change analysts auguring a rise in sea level in the shorebirds habitats that will send populations into continuous decline until the end of the 21st century. The goal of this research project is to analyze the quality of some of the main coastal ecosystems in South America and identify the short- and medium-term effects of climate change and other potential threats facing these species and their habitats. The team conducting the research includes scientists from Spain, Argentina and Chile.

THE WORLDS MOST PRIMITIVE MARSUPIAL

The BBVA Foundation Research Grants Program in Ecology and Conservation Biology will also be lending its support to a two-year study into the conservation status of the worlds oldest known marsupial species, the monito del monte (literally little mountain monkey) inhabiting the temperate forests of Southern Chile. The fact the species has survived thus far owes to the exceptional combination of ecological and evolutionary circumstances that characterize these forests, which have conserved their ancestral botanical and ecological legacy through major climate changes and tectonic shifts.

EFFECTS OF NOISE POLLUTION ON TRO
'"/>

Contact: Javier Fernandez
comunicacion@fbbva.es
Fundacin BBVA
22-Jun-2007


Page: 1 2 3

Related biology news :

1. Gilbert Foundation and American Fed for Aging Research award grants on Alzheimers disease
2. European Science Foundations Forward Look reaches out beyond the endless frontiers
3. Elsevier partners with National Natural Science Foundation of China
4. NY Stem Cell Foundations 2nd Annual Translational Stem Cell Research Conference
5. ACMG Foundation announces 2007-2008 Luminex/ACMGF award recipient
6. Computer science professor awarded $400,000 from National Science Foundation
7. UTSA neurobiologist awarded $225,000 from Whitehall Foundation
8. Juvenile Diabetes Research Foundation salutes passage of Senate stem cell bill
9. Pezcoller Foundation-AACR International Award for Cancer Research recognizes Mina J. Bissell
10. Grant to Yale from Simons Foundation to explore genetic causes of autism
11. Dr. John A. Martignetti receives 2006 Prostate Cancer Foundation Award

Post Your Comments:
(Date:5/14/2015)... , May 14, 2015 Research and Markets ... of the "Fingerprint Sensors Market in Smart Mobile ... This report believes that 2014 was a watershed year ... Apple,s introduction of ,Apple Pay,. Apple gave fingerprint sensors ... mobile payment service. Fingerprint sensors are a must-have feature ...
(Date:5/11/2015)... DAYTON, Ohio , May 11, 2015  Through a ... Ohio had a strong showing at AUVSI,s ... . These representatives of Ohio,s UAS ... domestic and abroad from all points along the UAS ecosystem. ... Dayton Development Coalition,s (DDC) Vice President for Aerospace Rich ...
(Date:5/8/2015)... May 8, 2015 Synaptics Inc. (NASDAQ: SYNA ... that members of the executive management team will present at ... Technology, Media and Telecom Conference Date: May 18, 2015 ... Boston, MA Cowen and Company ... 2:45pm ET Location: The New York Palace Hotel, ...
Breaking Biology News(10 mins):Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2Synaptics to Present at Upcoming Investor Conferences 2
(Date:5/21/2015)... 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the ... develops and commercializes proprietary technologies and products for advanced ... for the second fiscal quarter ended March 31, 2015. ... to advance business with our existing customers and to ... and CEO of SQI. "The delivery of a fully ...
(Date:5/21/2015)... San Francisco, CA (PRWEB) May 21, 2015 ... microbiome sequencing, has announced a partnership with PicnicHealth, ... records for patients. Participants diagnosed with Inflammatory Bowel ... as well as a complementary uBiome research kit. ... Summer 2014. , For more ...
(Date:5/21/2015)... LOS ANGELES , May 21, 2015 /PRNewswire/ ... research and development company specializing in oncology, today ... 2 clinical trial with aldoxorubicin for the treatment ... of brain cancer.  The open-label, multisite trial is ... of aldoxorubicin in patients whose tumors have progressed ...
(Date:5/21/2015)... 2015 Tunnell Consulting, Inc. ... as senior statistician and Principal, a position to which ... the management and analysis of complex and large data ... , “We’re delighted to have Julia join the Tunnell ... said Dr. Philippe Cini, Group Vice President and leader ...
Breaking Biology Technology:SQI Diagnostics Reports Second Quarter Financial Results 2SQI Diagnostics Reports Second Quarter Financial Results 3SQI Diagnostics Reports Second Quarter Financial Results 4SQI Diagnostics Reports Second Quarter Financial Results 5SQI Diagnostics Reports Second Quarter Financial Results 6SQI Diagnostics Reports Second Quarter Financial Results 7SQI Diagnostics Reports Second Quarter Financial Results 8uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2
Cached News: